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Abstract
Background: The diagnosis of Sudeck’s syndrome stage 1 (nowadays termed complex regional pain syndrome I,
abbreviated CRPS I) is based on clinical features, namely swelling and pain in a limb. Plain X-ray may be normal. In
the absence of pain sensitivity, e.g. in diabetic neuropathy, CRPS I of the foot can be mistaken for Charcot’s foot
stage 0 (so-called neuro-osteoarthropathy).
Case presentation: The case of a type-1 diabetic woman is reported, in whom CRPS I following a calcaneal
fracture was mistaken for Charcot’s osteoarthropathy (because of bone marrow edema displayed by conventional
MR imaging). In addition, a review is presented on 6 consecutive cases with CRPS I of the foot, and on 20 cases
with Charcot’s foot stage 0, with particular emphasis on MR imaging findings. The number of bones per foot
affected with marrow edema was similar in either condition, with a tendency towards a more patchy, diffuse
distribution of bone marrow edema in CRPS I. Bone marrow edema apparently regressed more promptly in
response to treatment in Charcot’s foot stage 0.
Conclusion: Differentiation of CRPS I from Charcot’s foot stage 0 remains a diagnostic dilemma in patients with
pain insensitivity. Conventional MRI may be helpful, when repeated for monitoring the treatment response.
Introduction
The diagnosis of Sudeck’s syndrome stage 1 (synonyma:
acute Sudeck’s disease, warm phase of algodystrophia,
complex regional pain syndrome I, CRPS I [1,2]) is based
on clinical features, including inflammatory painful swel-
ling and erythema of a limb, preceded by a skeletal
trauma in most cases. The case of a woman with type-1
diabetes mellitus is reported, who developed CRPS I fol-
lowing a calcaneal fracture, and in whom this condition
was mistaken for diabetic Charcot’s foot stage 0 on the
basis of MR imaging. This case prompted us to review
the effectiveness of conventional MRI in patients with
either CRPS I, or Charcot’s foot stage 0, respectively.
Case presentation
A 57-year old female nurse with type-1 diabetes since
t h ea g eo f1 2 ,w h ow a sf r e ef r o ma n yd i a b e t i c
complications (retinopathy, neuropathy, nephropathy),
fell off her bicycle and injured her right foot. She was
immediately admitted to hospital where an X-ray was
made and the diagnosis of an acute non-displaced cal-
caneal fracture was established. She was provided with
a walking cast and discharged home. Six weeks later,
the foot became swollen, hot, and extremely painful.
She could no longer walk on it. Repeat X-ray did not
show any more calcaneal fracture nor other abnormal-
ities. After 4 more weeks, the patient was referred to
the diabetic foot clinic because of presumed Charcot’s
foot stage 0 [3,4]. On examination, the foot was swol-
len, warm, erythematous (Figure 1), and extremely
painful even to light touch. MR imaging showed soft
tissue edema and patchy bone marrow edema in the
talus, calcaneus, cuboid and proximal phalanx of the
first toe (Figure 2) consistent with neuro-osteoarthro-
pathy (Charcot’s foot stage 0, according to the radiolo-
gist in charge). The patient was provided with a total
contact cast [5], which she could not tolerate; she used
a wheelchair instead. Even after 4 weeks of offloading,
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unusual for a Charcot’s foot. Hence, the diagnosis was
revised, and CRPS I was considered instead. The treat-
ment was modified accordingly, and physiotherapy
(active and passive foot exercises, warm and cold foot-
baths) was applied in addition to continuing offloading.
Four months later (7 months after onset of CRPS I),
swelling and pain had regressed, and gradually increas-
ing load-bearing was advised. Repeat MRI showed fluc-
tuating patchy bone marrow edema, with a tendency
to regress. Ten months after onset of symptoms, the
patient still had not fully recovered, while the MRI dis-
played further regression of the bone marrow edema
a n ds o f tt i s s u ee d e m a( F i g ures 3 and 4), consistent
with improved CRPS I.
Review of conventional MR imaging
In diabetic patients with insensitive feet due to diabetic
neuropathy, CRPS I of the foot [1,2,6-10] may exhibit
symptoms similar to acute Charcot’s foot stage 0 [3-5]
(Figures 1 and 5). Pain as the general symptom is more
or less absent, and plain X-ray may be normal in either
condition. Other imaging techniques may, thus, be
required in those patients. Therefore, we reviewed MRI
features in patients with either condition (Figures 2 and
6) in order to assess the diagnostic value of conventional
MR imaging.
Materials and methods
Clinical records of patients with established CRPS I
(according to the Budapest criteria [2]) of a foot, under
care of the Department of Traumatology, Orthopedic
and Reconstructive Surgery at the Berufsgenos-
senschaftliche Klinik (a tertiary reference centre for
vocational injuries in the region of Northrhine-
Figure 1 Appearance of the case patient’s right foot: hot, red,
swollen, extremely painful without stimulus (CRPS I).
Figure 2 Same foot as in Figure 1. MRI sagittal STIR-sequence
shows edema of skin and subcutaneous tissue with diffuse and
patchy bone marrow edema in the calcaneus, talus, distal tibia and
in the anterior tarsus (CRPS I).
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Likewise, files of patients with established diabetic
Charcot’s foot stage 0, under care of the diabetes foot
clinic at the Heinrich-Heine-University of Düsseldorf/
Germany between 1997 and 2007 [11], were reviewed
in retrospect. Only cases were included, in whom con-
ventional MRI studies and follow-up data were
available.
Definitions
CRPS I of the foot was defined by disproportionate
painfulness, allodynia, swelling, hyperthermia, erythema
and decreased range of motion [1,2]. Diabetic Char-
cot’s foot stage 0 (according to a modified Eichen-
holtz-scale[4]) was defined by severe sensory
neuropathy of the feet (vibration, sensation at the first
metatarsal head < 4/8 Rydel-Seiffer tuning fork grade
[12,13]), disproportionate painlessness, and swelling,
hyperthermia, erythema, decreased range of motion of
a foot; plain X-ray had to be normal, and skeletal
deformities had to be absent [3-5]. As we have shown
previously, this stage of Charcot’sf o o tr e p r e s e n t sa
“silent"-i.e. disproportionally painless- stress injury of
the foot skeleton in patients with sensory neuropathy
[11-14], see Figures 5,6,7,8.
MRI studies
Conventional MR examinations (with contrast media,
except for 7 cases) were performed on a 1.5 Tesla
superconducting magnet. Each foot was scanned in
sagittal view using T1-weighted turbo-spin-echo (TSE)
sequences (TR: 580, TE: 15) with a slice thickness of 3-4
mm. Paracoronal T1-weighted TSE-sequences were
acquired parallel to the midfoot through tibia, calcaneus
und talus. Sagittal T2-fat-suppressed-STIR-sequences
(TR: 3200, TE: 27, TI 160 msec) were also acquired.
Bone marrow edema was defined and charcterized by
intermediate to low signal on T1-weighted imaging
(T1w).
On fat-suppressed T2-weighted STIR- sequences
(short-tau inversion recovery), bone marrow edema
appears hyperintense compared to normal low signal
intense marrow [15,16].
Figure 3 Same foot as in Figure 1. 10 months after onset of CRPS
I (residual CRPS I).
Figure 4 Same foot as in Figure 3. Follow-up MRI sagittal STIR-
sequence shows patchy regredient bone marrow edema.
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Patients were treated at the discretion of the physicians
in charge. Offloading and immobilisation of the foot by
using a total contact cast [5] or wheelchair was applied
in cases with Charcot’s foot. Various drugs (analgesics,
calcitonin, pregabalin, bisphosphonates, vitamin D3,
calcium), orthopaedic footwear, crutches and/or
physiotherapy were applied in cases with CRPS I.
Statistics
Data are presented descriptively as means with 95% con-
fidence intervals, unless stated otherwise; Student’s t-test
was applied. Significance was assumed at a p < 0.05.
Results
Out of 17 cases of CRPS I of the lower limb referred to
the Department of Traumatology, Orthopedic and
Reconstructive Surgery, only 6 cases (including the case
patient) had CRPS I of a foot. In 5 of these cases, calca-
neal fracture was the inciting event, in 1 case it was
elective arthroscopic surgery at the talus; first MR ima-
ging was performed 11(95%CI 6-16) weeks thereafter.
Figure 5 Example of a Charcot’sf o o ts t a g e0 . Hot, red, swollen,
moderately painful only upon load bearing.
Figure 6 Same foot as in Figure 5. MRI sagittal STIR-sequence
shows a circumscript edema with skin thickening at the midfoot
and the anterior tarsus, with bone marrow edema in the navicular
and medial cuneiform bones (white arrows), and edema of adjacent
soft tissues (stress injury grade III).
Figure 7 Same foot as in Figure 5, after 3 months of offloading
and immobilisation (healed Charcot foot stage 0, restitution ad
integrum).
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the diabetic foot clinic [11], 20 cases had Charcot’sf o o t
stage 0 and fulfilled the selection criteria. In these
patients, first MR imaging was performed 5.5(95%CI
2.7-7.4) weeks after onset of symptoms (p < 0.05 versus
patients with CRPS I), showing a stress fracture (grade
IV according to Kiuru et al., [14]) of the talus or calca-
neus in 3, and of a tarsal or metatarsal bone in 4
patients, respectively, as inciting event. The clinical
characteristics of all audited cases are summarised in
Table 1. CRPS I patients were younger and free from
sensory deficits, whereas all Charcot’s patients had poly-
neuropathy by definition.
The findings on the conventional MR images are also
summarized in Table 1. Charcot’s feet responded to
treatment by clinical and MRI regression immediately
and were healed after 20(95%CI 15-24) weeks. By con-
trast, CRPS I syndrome fluctuated in symptoms and
activity and required significantly longer to heal [43(95%
C I3 0 - 7 6 ) w e e k s ] ;t w oc a s e sh a dn o th e a l e da tt h et i m e
of writing this report.
Discussion
The case of our patient demonstrates the diagnostic
d i l e m m at h a te x i s t si np a t i e n t sw i t hd i a b e t e sm e l l i t u s
and a red, hot, swollen foot with a normal X-ray: clinical
symptoms (except for pain quality) as well as MRI find-
ings seem to be suggestive of both, CRPS I, or Charcot’s
foot stage 0.
CRPS I at the foot is very painful in diabetic and non-
diabetic subjects alike: pain is spontaneous, severe, com-
bined with allodynia and hyperalgesia-provided pain
sensitivity is normal. By contrast, in diabetic Charcot’s
foot stage 0 there may be some stress-related pain that
subsides upon offloading, but at rest there is little or no
spontaneous pain or allodynia- because pain sensitivity
is reduced or absent (due to diabetic neuropathy). How-
ever, in patients with diabetic neuropathy, CRPS I at the
foot may be abnormally painless- and may, therefore, be
mixed up with the more common Charcot’s foot stage 0.
MRI features of CRPS I (Sudeck’ss y n d r o m es t a g e1 )
at the foot were demonstrated for the first time by
Schimmerl et al. [6]. They showed that in CRPS I bone
marrow displays diffuse or spotted hyperintensities
("bone marrow edema”) on STIR images, and contrast
media enhanced thickening of periarticular and/or sub-
cutaneous and skin tissue. These features, which were
confirmed repeatedly [7-10,17] are still not fully under-
stood; increased permeability of small intramedullary
and soft tissue vessels due to an unknown stimulus
could be causally involved.
MRI features of Charcot’s foot stage 0 (in insensitive
feet of patients with diabetic neuropathy) were demon-
strated previously: subchondral ("traumatic”)b o n e
marrow edema, occasionally triggering neuro-osteoar-
thropathy (Charcot’s foot stage I-III) [11-13,18]. In this
Figure 8 Same foot as in Figure 7. MRI sagittal STIR-sequence
shows regression of bone marrow edema (white arrows) and soft
tissue edema.
Table 1 Patient characteristics and MRI features
Patients CRPS I Charcot’s foot stage 0, no deformity
Total number 6 20
- males/females, n 5/1 10/10
- Age, years 47 (95% CI 40-55) 62 (95%CI 59-65)*
- BMI > 29 kg/m², n 0 4
- Diabetes mellitus, n 1 20**
- Polyneuropathy, n 0 20**
MRI features
Bones with BME per foot, n 3.7(95% CI 1.8-5-5) 4.3(95% CI 3.0-5.6)
Feet with diffuse patchy BME, n 3 (50%) 0 (0%)
Feet with migrating and/or fluctuating BME, n 3 (50%) 0 (0%)
Feet with soft tissue edema, n 5 (83%) 20 (100%)
* p < 0.05; ** by definition. BMI = body mass index; BME = bone marrow edema.
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bone or joint contusion, osteitis, or stress-induced trabe-
cular microfracture [14-16,18,19], respectively.
The MRI findings in the present study are not straight-
forward. In CRPS I, bone marrow edema (and soft tissue
edema) seemed to be distributed in a more patchy and dif-
fuse fashion (as compared to the more focal distribution in
Charcot’s foot stage 0), and to be more fluctuating in
response to treatment (in 3 out of our 6 patients, see
Figure 2 and 4). It has been reported previously that in
CRPS I, bone marrow edema may fluctuate and migrate to
neighbouring bones during the natural regression of the
acute (warm) phase [7-9]. In Charcot’s foot stage 0, how-
ever, the bone marrow edema regresses steadily (without
fluctuation and migration) in response to strict offloading
and immobilisation, like any other traumatic bone marrow
edema does [11-14,20], see Figures 6 and 8. Correspond-
ingly, the inflammatory activity-edema, hyperthermia- in a
Charcot’s foot stage 0 may respond within 3 months of
offloading and immobilisation by total contact cast [21],
whereas inflammation may fail to respond similarly to the
particular therapy in a foot with CRPS I [22].
Conclusions
In conclusion, although conventional MRI displays dis-
tinct skeletal pathology in cases of CRPS I of the foot,
and Charcot foot stage 0, respectively, it seems to lack
specificity for either condition. Hence, conventional
MRI signs have to be interpreted carefully within the
clinical context. Further study is warranted to determine
the potential of more sophisticated MR imaging techni-
ques like dynamic gadolinium enhanced MRI [23] or
diffusion weighted MRI in these conditions.
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